These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1187555)

  • 21. Deanol in minimal brain dysfunction.
    Lewis JA; Lewis BS
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):21-4. PubMed ID: 590062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary 3-methoxy-4-hydroxyphenylglycol sulfate in school children with minimal brain dysfunction syndrome].
    Wang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Feb; 18(1):45-9. PubMed ID: 3987458
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of effect of TRH in minimal brain dysfunction.
    O'Tuama LA; Swisher CN; Reichler RJ; Routh DK
    Pediatrics; 1977 Jun; 59(6):955-6. PubMed ID: 405652
    [No Abstract]   [Full Text] [Related]  

  • 24. [Amphetamines in the treatment of hyperactive and instable children].
    Glós J
    Cesk Pediatr; 1973 Oct; 28(10):559-60. PubMed ID: 4766681
    [No Abstract]   [Full Text] [Related]  

  • 25. Blue toes after stimulant therapy for pediatric attention deficit hyperactivity disorder.
    Al Aboud A; Abrams M; Mancini AJ
    J Am Acad Dermatol; 2011 Jun; 64(6):1218-9. PubMed ID: 21571204
    [No Abstract]   [Full Text] [Related]  

  • 26. [Minimal brain dysfunction. III. Treatment (preliminary report)].
    Rafael Cruz H; Valadez MT
    Salud Publica Mex; 1987; 29(1):55-60. PubMed ID: 2885925
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebral dysfunctions-clarification, delineation, classification.
    Block WM
    PDM; 1974; 5-6(9-12;1-8):21-5. PubMed ID: 4464490
    [No Abstract]   [Full Text] [Related]  

  • 28. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 29. A long-term comparison of two treatment regimens for minimal brain dysfunction. Drug therapy versus combined therapy.
    Friedman R; Dale EP; Wagner JH
    Clin Pediatr (Phila); 1973 Nov; 12(11):666-71. PubMed ID: 4759509
    [No Abstract]   [Full Text] [Related]  

  • 30. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
    Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
    J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Child psychiatry--the continuing controversy. Minimal cerebral (brain) dysfunction--clinical fact or neurological fiction? The syndrome critically re-examined in the light of some hard neurological evidence.
    Becker RD
    Isr Ann Psychiatr Relat Discip; 1974 Jun; 12(2):87-106. PubMed ID: 4606334
    [No Abstract]   [Full Text] [Related]  

  • 32. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative Exploration of the Experiences of People Who Use Captagon and Therapists in Jordan.
    Wazaify M; Al-Khateeb YM; Musleh B; Al-Smadi H; Steenkamp C
    Subst Use Misuse; 2024; 59(5):816-824. PubMed ID: 38263603
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyperkinetic behavior syndrome. An interdisciplinary study of the basis for rational medical treatment].
    Diderichsen J; Ruud E
    Tidsskr Nor Laegeforen; 1988 Feb; 108(6):481-3, 465. PubMed ID: 3281323
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
    J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder.
    Donner R; Michaels MA; Ambrosini PJ
    Biol Psychiatry; 2007 Mar; 61(5):706-12. PubMed ID: 16899230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenethylline (Captagon) Abuse - Local Problems from an Old Drug Become Universal.
    Katselou M; Papoutsis I; Nikolaou P; Qammaz S; Spiliopoulou C; Athanaselis S
    Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):133-40. PubMed ID: 27004621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.
    Ambrosini PJ; Sallee FR; Lopez FA; Shi L; Michaels MA;
    Curr Med Res Opin; 2006 Feb; 22(2):427-40. PubMed ID: 16466615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.